You are here

pazopanib

Merck and GlaxoSmithKline partner to evaluate renal cell carcinoma regimen

The Fly on the Wall

Wed, 12/18/13 - 09:16 am

renal cell carcinoma

FDA advisers unanimously back GlaxoSmithKline drug for kidney cancer, despite liver risks

Yahoo/AP

Tue, 10/6/09 - 10:46 am

Glaxo Kidney Cancer Drug Has Liver Risk, FDA Says

Bloomberg

Thu, 10/1/09 - 09:44 am